MECHANISMS OF ACTION OF AMINOGLUTETHIMIDE AS ENDOCRINE THERAPY OF BREAST-CANCER

被引:112
作者
LONNING, PE
KVINNSLAND, S
机构
关键词
D O I
10.2165/00003495-198835060-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:685 / 710
页数:26
相关论文
共 221 条
[1]  
ABOULENEIN A, 1983, 2ND INT C HORM CANC
[2]  
ABULHAJJ YJ, 1982, CANCER RES, V42, P3373
[3]   THE EFFECT OF ACETYLATOR PHENOTYPE ON THE DISPOSITION OF AMINOGLUTETHIMIDE [J].
ADAM, AM ;
ROGERS, HJ ;
AMIEL, SA ;
RUBENS, RD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (04) :495-505
[4]  
ADAM AM, 1985, CANCER CHEMOTH PHARM, V15, P176
[5]  
AHMANN FR, 1987, CANCER RES, V47, P4736
[6]   A CLINICAL-TRIAL OF AMINOGLUTETHIMIDE IN ADVANCED POSTMENOPAUSAL BREAST-CARCINOMA - LOW RESPONSE IN PATIENTS PREVIOUSLY TREATED WITH MEDROXYPROGESTERONE [J].
ALBERTO, P ;
MERMILLOD, B ;
KAPLAN, E ;
GOLDHIRSCH, A ;
OBRECHT, JP ;
JUNGI, F ;
MARTZ, G ;
BARRELET, L ;
CAVALLI, F .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (04) :423-428
[7]  
APPELGREN LE, 1985, 2ND SCAND BREAST CAN
[8]  
ASBURY RF, 1981, CANCER, V47, P1954, DOI 10.1002/1097-0142(19810415)47:8<1954::AID-CNCR2820470807>3.0.CO
[9]  
2-E
[10]  
BAKER MH, 1981, BRIT J PHARMACOL, V74, P243